Clinical Trial Update: Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient Children [Phase 3]

View source ↗

Summary

Phase 3 trial of somatropin (Norditropin) in insulin-like growth factor (IGF) deficient children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency
• Pituitary Dwarfism

Drugs mentioned

• Norditropin (somatropin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Growth Hormone Disorder, Pituitary Dwarfism | Phase 3 | Status: COMPLETED